NCT04026516Completed
CAVA: Dizziness Trial
Production of a Device to Obtain Continuous Ambulatory Vestibular Assessment (CAVA) - Dizziness Trial
Source: ClinicalTrials.gov · Last updated 10 Aug 2026
Brief summary (registry, in English)
Clinical investigation of a medical device (CAVA) for recording eye movements. Patients suffering from diagnosed dizziness conditions will wear the device for 23 hours a day, for 30 days. The device will capture normal eye movement data as well as data corresponding to any dizzy events experienced. At the end of the trial, the data will be downloaded and a scientist will perform a blinded analysis of the data. Specifically, they will attempt to identify the dates on which dizziness was reported.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 29 (actual)
- First submitted
- 8 Jul 2019
- Start date
- 1 Jul 2019
- Primary completion date
- 31 Oct 2025
- Lead sponsor
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- Diseases
- Migraine
- NCT number
- NCT04026516
What you commit to
- Study type: Interventional
- Participants enrolled: 29
- From 1 Jul 2019 to the primary completion date, 31 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of ear disease, or previous ear surgery.
- History of eye disease, or previous eye surgery.
- Potential participants who have taken part in a previous CAVA trial.
- Potential participants who are currently taking part in another trial.
Other illness
- Potential participants who have a history of dermatological disease, fragile skin, or damage around the forehead.
- Potential participants who have an allergy to plasters and/or medical adhesives - (similarly to materials used in the device).
- History of hypertension or cardiac problems (uncontrolled, acute or de-compensated - phase).
- History of psychotic/neurotic disorders or epilepsy.
Other
- Pregnant or nursing mothers.
- Unable to follow the testing protocol.
Who the study is looking for
- Adults aged 18 and over.
- Patients experiencing episodes of true vertigo, with at least two episodes within the preceding month. Relevant medical conditions include Meniere's disease, Benign Paroxysmal Positional Vertigo (BPPV), recurrent vestibulopathy and vestibular migraine.
- Able to commit to 30 days of continuous wear of the trial device as per the study plan.
- Own a telephone.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Norfolk & Norwich University Hospitals NHS Foundation Trust Coordinator of this site? Confirm its status | Norwich | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.